Navigation Links
New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir

Minimal Weight Change Reported Unlike What Is Commonly Seen In Insulin Therapy

CHICAGO, June 24, 2007 – Novo Nordisk today announced results of a new study that further demonstrated the safety and efficacy of insulin Levemir® (insulin detemir [rDNA origin] injection). Patients with Type 2 diabetes were able to adjust their own dosage of Levemir® and achieve improvements in blood sugar, comparable to dosing adjusted by their primary care physician. This improvement in A1c levels was observed with minimal weight change and without increases in rates of hypoglycemia. The data were presented at the 67th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois.

“The study is a testament to the safety of Levemir®, as patients were able to adjust their basal insulin dose on their own and achieve the same level of glycemic control as when guided by their doctor, while reducing the risk of hypoglycemia” said Luigi Meneghini, MD, MBA, Associate Professor of Clinical Medicine and the Director of the Eleanor and Joseph Kosow Diabetes Treatment Center at the Diabetes Research Institute, Miami, FL. “Since having Type 2 diabetes requires a great deal of self-management, these findings will help empower patients to work more closely as partners with their physician to take control of their insulin treatment. The potential of improved self-management is made possible by insulin analogs like Levemir®, which provide effective basal insulin coverage, and, as shown in this study, the added benefit of minimal weight change.”

The new data were obtained from the insulin detemir 303 Algorithm tested in a Randomized Clinical Trial: The US PREDICTIVE™ 303 Trial (Predictable Results and Experience in Diabetes through Intensification and Control to Target: An International Variability Evaluation), which included 5,604 patients. The da
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:7/2/2015)... , 2. Juli 2015 BGI gab ... in Hongkong vom American College of Pathologists ... ist das erste klinische Next-Generation-Sequencing Labor, das ... CAP-Zertifkat erhält und somit die höchsten Standards ... bestehenden US FDA - 21 CFR Part ...
(Date:7/2/2015)... 2, 2015  The Commission for Certification in ... an organization that represents pharmacists in acute and ... continuing education for recertification of Certified Geriatric Pharmacists.  ... programs for this purpose.  ASHP will join the ... for the CCGP Professional Development Program. ...
(Date:7/2/2015)... , South Korea, July 2, 2015 ALPINION MEDICAL ... new E-CUBE Series ultrasound system. Developed to enhance user ... areas, the E-CUBE 15 EX produces superb image quality. ... performance in women,s health, general imaging, and shared service ... The latest in the renowned E-CUBE Series, the E-CUBE ...
Breaking Medicine Technology:BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2Commission for Certification in Geriatric Pharmacy Adds ASHP as Professional Development Program Provider 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3
... 2011 The Pennsylvania State Police will accept unwanted, expired ... part of National Prescription Drug Take Back Day. ... is to raise awareness of the problem with prescription-drug ... of unused, unwanted and expired prescription drugs," State Police ...
... SILVER SPRING, Md., Oct. 26, 2011 The U.S. ... $2 million to support two regional Centers of Excellence ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) The centers, which will ... University, will focus on strengthening science and training needed ...
Cached Medicine Technology:FDA Invests $2 Million in Partnerships Through Centers of Excellence in Regulatory Science and Innovation 2
(Date:7/2/2015)... Vancouver, BC (PRWEB) , ... July 02, 2015 , ... With summer in full swing, ... , Canada is one of the top spots for fishing in the world, and it’s ... and rivers of Ontario, Canada has great fish. , Recreational fishing is a huge ...
(Date:7/2/2015)... ... , ... As Americans celebrate the Fourth of July outdoors this weekend, local ... rise. July is UV Safety Month, and physicians at American Family Care and AFC ... checks. Experts say most skin cancers can be found early with regular skin exams. ...
(Date:7/2/2015)... ... 02, 2015 , ... Six months ahead of his 80th birthday, Don Stevenson ... and money for the Pulmonary Hypertension Association (PHA). Stevenson began the walk in ... D.C. by mid-September. He left Glasgow, Mont. yesterday morning and is making his way ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... Delivery Coalition met for the late June Web-based session, the speakers discussed the ... schemes and managing high-risk patients through coordinated care. , During the session, participants ...
(Date:7/2/2015)... Jeffersonville, Pennsylvania (PRWEB) , ... ... ... nation’s largest e-commerce janitorial supply company , announced today that it ... Commercial Products. The acquisition will make CleanItSupply.com the largest distributor of Rubbermaid ...
Breaking Medicine News(10 mins):Health News:Local Physicians Warn of Holiday Health Hazards 2Health News:Local Physicians Warn of Holiday Health Hazards 3Health News:Local Physicians Warn of Holiday Health Hazards 4Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:CleanItSupply.com Acquires eRubbermaid.com 2
... the risk of heart attack //for people. ,The research, ... Periodontology, say that people with periodontal disease who have suffered ... the ones whose total number of periodontal bacteria in sub ... of the study. Researchers had looked into the gum state ...
... from Filarial infection and some// get grotesque condition called elephantiasis, ... is caused by a pathogen called wuchereria bancrofti, this is ... body’s lymph nodes where they cause the blockage of the ... like the legs or genitalia like the scrotum, penis or ...
... in children of patients with Alzheimers// was thought to be ... might increase the anxiety or depression in children of the ... may not be true. Genetical testing has no effect on ... the participants of the study felt empowered from knowing the ...
... has prohibited the sale and manufacture of the drug// ... under the Drugs and Cosmetics Act. , ,Studies ... found to double the risk of heart attacks and ... ,Although some of the leading pharmaceutical companies have stopped ...
... can successfully detect the changes in the brain // ... Researchers behind the study feel that this may prove ... the brain chemical levels that will get long lasting ... ,Cognitive behavior therapy is a new kind ...
... Early recurrence of thyroid cancer may be detectable using ... ‘Thyroglobin”(Tg) according to a study published by researchers ... and Arthur G. James Cancer Hospital and Richard J. ... 21 online in the Journal of Clinical Endocrinology & ...
Cached Medicine News:Health News:Antibiotics help combat dangerous tropical disease 2Health News:Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available 2
Straight shafts with pointed 4.5 mm tying surfaces. Scalloped wide handle with dull finish....
Straight, heavy shafts with 0.12 mm teeth and 5.5 mm tying platform. Wide serrated handle with polished finish....
Angled 45 degree shafts with 0.5 teeth and 6 mm tying platform. Polished finish....
Straight shafts with 0.12 mm teeth and tying platform. Serrated handle with polished finish....
Medicine Products: